NAM new members include Sharpless, Tuveson, Fowler, Karikó, Mackall, Polyak, Campbell, Eaves, Shi, Frederick, Glazer, Gutmann, Markert, Mischel, Quackenbush, Rathmell October 21, 2022Vol.48 No.38
FreeIn the Archives Bone marrow transplantation: Dottie Thomas, primary sources, and controversies October 21, 2022Vol.48 No.38
Conversation with The Cancer Letter Fred Hutch receives $710.5M from Bezos family to speed up clinical trials, translational research, recruitmentGift is part of a 10-year $3B fundraising effort October 14, 2022Vol.48 No.37By Paul Goldberg
Guest Editorial What did we REALLY learn from the NordICC colonoscopy study? October 14, 2022Vol.48 No.37By William L. Dahut
Guest Editorial NordICC colonoscopy study results should be viewed with caution—longer follow-up needed October 14, 2022Vol.48 No.37By Roopa Vemulapalli
Guest Editorial Assessing the prospect of tactical nuclear weapons use in Ukraine October 14, 2022Vol.48 No.37By Robert Peter Gale
Cancer History ProjectConversation with The Cancer Letter Viral oncology’s complicated path—from cancer as contagion to today’s immunotherapy October 14, 2022Vol.48 No.37By Alexandria Carolan
FreeObituary Audrey Evans, trailblazing pediatric oncologist, first chief of oncology at CHOP, dies at 97 October 14, 2022Vol.48 No.37By John M. Maris
NCI Thrice Acting Director Lowy lays out vision of NCI future as Bertagnolli steps in October 07, 2022Vol.48 No.36By Matthew Bin Han Ong
